Aldawsari et al., 2020 - Google Patents
Rapid microwave-assisted cisplatin-loaded solid lipid nanoparticles: synthesis, characterization and anticancer studyAldawsari et al., 2020
View HTML- Document ID
- 16593566703301935445
- Author
- Aldawsari H
- Singh S
- Publication year
- Publication venue
- Nanomaterials
External Links
Snippet
Cisplatin is one of the most leading potent chemotherapy drugs prescribed for the treatment of most solid tumors. However, the induction of toxicities and the development of resistance restricts its applications. Efforts are made in the proposed study to control the delivery of …
- 229960004316 cisplatin 0 title abstract description 79
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Aldawsari et al. | Rapid microwave-assisted cisplatin-loaded solid lipid nanoparticles: synthesis, characterization and anticancer study | |
Lomis et al. | Human serum albumin nanoparticles for use in cancer drug delivery: process optimization and in vitro characterization | |
Halayqa et al. | PLGA biodegradable nanoparticles containing perphenazine or chlorpromazine hydrochloride: effect of formulation and release | |
Souto et al. | Perillaldehyde 1, 2-epoxide loaded SLN-tailored mAb: Production, physicochemical characterization and in vitro cytotoxicity profile in MCF-7 cell lines | |
Niza et al. | Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer | |
Go et al. | Prpc aptamer conjugated–gold nanoparticles for targeted delivery of doxorubicin to colorectal cancer cells | |
Xu et al. | pH and redox dual-responsive MSN-SS-CS as a drug delivery system in cancer therapy | |
Tao et al. | Effects of particle hydrophobicity, surface charge, media pH value and complexation with human serum albumin on drug release behavior of mitoxantrone-loaded pullulan nanoparticles | |
Khan et al. | FMSP-nanoparticles induced cell death on human breast adenocarcinoma cell line (MCF-7 cells): morphometric analysis | |
Aldawsari et al. | Gum acacia functionalized colloidal gold nanoparticles of letrozole as biocompatible drug delivery carrier for treatment of breast cancer | |
Nasr et al. | Bioavailability and antidiabetic activity of gliclazide-loaded cubosomal nanoparticles | |
Sun et al. | Nanoformulation of a novel pyrano [2, 3-c] pyrazole heterocyclic compound AMDPC exhibits anti-cancer activity via blocking the cell cycle through a P53-independent pathway | |
Tazhbayev et al. | Hydroxyurea-loaded albumin nanoparticles: Preparation, characterization, and in vitro studies | |
Zafar et al. | Development and optimization of hybrid polymeric nanoparticles of apigenin: Physicochemical characterization, antioxidant activity and cytotoxicity evaluation | |
Mahmoud et al. | Gold Nanocomplex strongly modulates the PI3K/Akt pathway and other pathways in MCF-7 breast cancer cell line | |
Shariare et al. | Development of stable liposomal drug delivery system of thymoquinone and its in vitro anticancer studies using breast cancer and cervical cancer cell lines | |
Liu et al. | Targeted co-delivery of gefitinib and rapamycin by aptamer-modified nanoparticles overcomes EGFR-TKI resistance in NSCLC via promoting autophagy | |
Fatemian et al. | Cytotoxicity enhancement in breast cancer cells with carbonate apatite-facilitated intracellular delivery of anti-cancer drugs | |
Mohan et al. | Optimising PLGA-PEG nanoparticle size and distribution for enhanced drug targeting to the inflamed intestinal barrier | |
Pramual et al. | PLGA-lipid hybrid nanoparticles for overcoming paclitaxel tolerance in anoikis-resistant lung cancer cells | |
Shehata et al. | Paclitaxel and myrrh oil combination therapy for enhancement of cytotoxicity against breast cancer; QbD approach | |
Carreón González et al. | Gold nanoparticles as drug carriers: the role of silica and peg as surface coatings in optimizing drug loading | |
Sunoqrot et al. | Vitamin E TPGS-poloxamer nanoparticles entrapping a novel PI3Kα inhibitor potentiate its activity against breast cancer cell lines | |
Kalyane et al. | CD44-receptor targeted gold-doxorubicin nanocomposite for pulsatile chemo-photothermal therapy of triple-negative breast cancer cells | |
Boztepe et al. | Design, synthesis, characterization, and evaluation of the anti-HT-29 colorectal cell line activity of novel 8-oxyquinolinate-platinum (II)-Loaded nanostructured lipid carriers targeted with riboflavin |